Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Grapefruit Benefits

AMAG Pharmaceuticals Announces U.S. Launch Of Feraheme ™ (ferumoxytol) Injection
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced that Feraheme ™ (ferumoxytol) Injection is now available for commercial sale in the United States. Feraheme is an intravenous (IV) iron replacement therapy for the treatment of iron deficiency anemia in adult patients with chronic kidney disease. Feraheme can provide patients with a 1 gram therapeutic course of iron in two 510 mg IV injections administered as quickly as 17 seconds each, within one week. Feraheme was approved by the U.S. Food and Drug Administration on June 30, 2009.
generic viagra online
Sequel Systems Supports Meaningful Use Workshop's Recommendations To Health IT Policy Committee
Sequel Systems, Inc. announced it supports the recommendations from the US. Department of Health and Human Services" Meaningful Use Workgroup for the definition of "meaningful use" as it pertains to electronic health records (EHR).
News of the day
Protecting The Value Of Long-Term Care Insurance
Today, U.S. Senators Mel Martinez (R-FL) and Herb Kohl (D-WI) of the Special Committee on Aging examined the long-term care insurance industry. The high cost of long-term care and the current economic instability are creating significant financial planning challenges for baby-boomers, seniors, and individual states. The committee discussed the industry"s current limitations and how to prepare for the growing number of seniors who will be in need of long-term care.
Nutrition

The European Biotech Industry Applauds UK Efforts To Place Industrial Biotech At The Center Of A Low Carbon Economy

EuropaBio, the European biotech industry association applauds the report "IB 2025: Maximising UK Opportunities from Industrial Biotechnology in a Low Carbon Economy" (1) released today by the UK"s Department for Business Enterprise and Regulatory Reform (BERR). The biotech industry welcomes the report which is completely in line with the EU"s Lead Market Initiative for Biobased Products (2). EuropaBio is also pleased to note that the report also embraces EuropaBio"s policy recommendations (3) developed to help the EU realise the vision of a Knowledge-Based Bio-Economy (KBBE). "A competitive European Knowledge-based Bioeconomy can only be realised when the European Union and the member states put a coherent policy framework in place. What has been done in the UK will motivate industry to continue investment in this emerging and innovative industrial sector" said Dirk Carrez, EuropaBio"s Director, Industrial Biotechnology. Over the last two years the biotech industry has supported the European Commission to work out a set of concrete steps to realise the vision of a Knowledge-Based Bio-Economy (KBBE), where biotechnology"s new, clean, energy-efficient processes and innovative biobased products create a sustainable industrial base to ensure Europe"s future prosperity. EuropaBio"s "Industrial Biotechnology Policy Agenda for Europe" (3) produced an outline of policy recommendations to develop a competitive KBBE in Europe, but recognized that in order for these recommendations to be implemented, political support was needed. "EuropaBio is pleased to note the support these recommendations have received from the UK government" said Willy De Greef, EuropaBio"s Secretary General. "Developing an innovation driven economy is at the core of the Lisbon partnership. It is only with support of the member states that the vision to support growth and jobs in Europe by stimulating innovation can be realized." Notes (1) IB 2025: Maximising UK Opportunities from Industrial Biotechnology in a Low Carbon Economy See here. (2) The Commission Website on the Lead Market Initiative (3) Industrial Biotechnology Policy Agenda for Europe EuropaBio


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009